Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
topic_facet:"Study Type: Interventional"
topic_facet:"Recruitment Status: Authorised-recruitment may be ongoing or finished"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22Study+Type%3A+Interventional%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields&page=11
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22Study+Type%3A+Interventional%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields&page=11
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22Study+Type%3A+Interventional%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields&page=11
PubPharm (1.434)
101
Isatuximab in combination with lenalidomide and dexamethasone in high-risk smoldering multiple myeloma : A Phase 3 randomized, open label, multicenter study of isatuximab (SAR650984) in combination with lenalidomide and dexamethasone versus lenalidomide and dexamethasone in patients with high-risk smoldering multiple myeloma
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
102
A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine A or for Those Who Cannot Take Oral Cyclosporine A Because it is Not Medically Advisable : A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Safety and Efficacy of Baricitinib in Combination with Topical Corticosteroids in Adult Patients with Moderate-to-Severe Atopic Dermatitis Who Have Experienced Failure to Cyclosporine or Are Intolerant to, or Have Contraindication to, Cyclosporine - BREEZE-AD4
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
103
Isatuximab in combination with lenalidomide and dexamethasone in high-risk smoldering multiple myeloma : A Phase 3 randomized, open label, multicenter study of isatuximab (SAR650984) in combination with lenalidomide and dexamethasone versus lenalidomide and dexamethasone in patients with high-risk smoldering multiple myeloma
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
104
A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine A or for Those Who Cannot Take Oral Cyclosporine A Because it is Not Medically Advisable : A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Safety and Efficacy of Baricitinib in Combination with Topical Corticosteroids in Adult Patients with Moderate-to-Severe Atopic Dermatitis Who Have Experienced Failure to Cyclosporine or Are Intolerant to, or Have Contraindication to, Cyclosporine - BREEZE-AD4
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
105
Phase 3 Study of Venetoclax and Dexamethasone Compared with Pomalidomide and Dexamethasone in Subjects with t(11;14)-Positive Relapsed or Refractory Multiple Myeloma : A Phase 3, Multicenter, Randomized, Open Label Study of Venetoclax and Dexamethasone Compared with Pomalidomide and Dexamethasone in Subjects with t(11;14)-Positive Relapsed or Refractory Multiple Myeloma
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
106
A Trial to Determine The Safety and Efficacy of CC-92480 Alone and When Combined With Dexamethasone in People Who Have Myeloma That is NotResponsive After Treatment or Who Had Myeloma Which Has Returned After a Period of Treatment : A Phase 1/2 Multicenter, Open-label Study to Assess the Safety, Pharmacokinetics and Efficacy of CC-92480 Monotherapy and in Combination with Dexamethasone in Subjects with Relapsed and Refractory Multiple Myeloma
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
107
Phase 3 Study of Venetoclax and Dexamethasone Compared with Pomalidomide and Dexamethasone in Subjects with t(11;14)-Positive Relapsed or Refractory Multiple Myeloma : A Phase 3, Multicenter, Randomized, Open Label Study of Venetoclax and Dexamethasone Compared with Pomalidomide and Dexamethasone in Subjects with t(11;14)-Positive Relapsed or Refractory Multiple Myeloma
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
108
A Trial to Determine The Safety and Efficacy of CC-92480 Alone and When Combined With Dexamethasone in People Who Have Myeloma That is NotResponsive After Treatment or Who Had Myeloma Which Has Returned After a Period of Treatment : A Phase 1/2 Multicenter, Open-label Study to Assess the Safety, Pharmacokinetics and Efficacy of CC-92480 Monotherapy and in Combination with Dexamethasone in Subjects with Relapsed and Refractory Multiple Myeloma
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
109
A clinical study that compares a treatment with Iberdomide, Daratumumab and Dexamethasone against a treatment with Daratumumab, Bortezomib, and Dexamethasone in patients with a non-responsive or progressive blood cancer called Multiple Myeloma : A Phase 3, Two-Stage, Randomized, Multicenter, Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Subjects with Relapsed or Refractory Multiple Myeloma (RRMM) - EXCALIBER-RRMM
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
110
A clinical trial comparing of 4 doses of CHF 5993 100/6/12.5 µg pMDI to 4 doses of CHF 1535 200/6 µg pMDI in subjects with asthma. : A 26 WEEK, RANDOMIZED, DOUBLE BLIND, MULTINATIONAL, MULTICENTRE, ACTIVE CONTROLLED, 2-ARM PARALLEL GROUP TRIAL COMPARING CHF 5993 100/6/12.5 µg pMDI (FIXED COMBINATION OF EXTRAFINE FORMULATION OF BECLOMETASONE DIPROPIONATE PLUS FORMOTEROL FUMARATE PLUS GLYCOPYRRONIUM BROMIDE) TO CHF 1535 200/6 µg pMDI (FIXED COMBINATION OF EXTRAFINE FORMULATION OF BECLOMETASONE DIPROPIONATE PLUS FORMOTEROL FUMARATE) IN SUBJECTS WITH ASTHMA UNCONTROLLED ON MEDIUM DOSES OF INHALED CORTICOSTEROIDS IN COMBINATION WITH LONG-ACTING ß2-AGONISTS. - MiSTIC
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
[1]
« Vorheriger
6
7
8
9
10
11
12
13
14
15
16
Nächster »
[144]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Filter aufheben
Thema: Study Type: Interventional
Filter aufheben
Thema: Recruitment Status: Authorised-recruitment may be ongoing or finished
Medienart
1.434
Aufsätze
1.434
E-Artikel
1.434
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
1.434
610
Recruitment Status: Authorised-recruitment may ...
Study Type: Interventional
718
Phase: Phase 3
276
Phase: Phase 2
124
Medical Condition: Multiple Myeloma MedDRA vers...
116
Phase: Phase 4
50
Phase: Phase 1
40
Medical Condition: Multiple myeloma MedDRA vers...
40
Medical Condition: Relapsed/Refractory Multiple...
36
Medical Condition: Relapsed or Refractory Multi...
24
Medical Condition: Plasma cell myeloma MedDRA v...
24
Medical Condition: Relapsed or Refractory Multi...
24
Medical Condition: Smoldering Multiple Myeloma ...
22
Medical Condition: ASTHMA UNCONTROLLED ON MEDIU...
22
Medical Condition: Moderate and Severe Atopic D...
20
Medical Condition: Patients with Relapsed Refra...
16
Medical Condition: MULTIPLE MYELOMA MedDRA vers...
16
Medical Condition: Relapsed and lenalidomide-re...
12
Medical Condition: Atopic Dermatitis MedDRA ver...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
862
2020-
572
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
1.382
Englisch
38
Unbestimmt
8
Französisch
4
Dänisch
2
Spanisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...